Characteristic Stepwise (N=111) LA PWI (N=111) p-value
Mean Age – years + SD 63.6 + 10.5 65.4 + 10.1 0.2
Male sex – no. (%) 85 (76.6) 86 (77.5) 0.9
Ejection fraction – % + SD 55.3 + 10.2 55.2 + 13.1 0.9
Left atrial diameter – no. + SD 4.4 + 0.6 4.4 + 0.7 0.6
Mean BSA (m2) – no. + SD 2.1 + 0.26 2.1 + 0.24 0.9
Mean NPAF Duration – days + SD 546.4 + 1104.2 375.8 + 592 0.2
Medical history – no. (%)
Hypertension 73 (66) 73 (66) 1
Diabetes 13 (11.7) 17 (15.3) 0.4
Coronary disease 24 (21.6) 30 (27) 0.3
Stroke or transient ischemic attack 11 (9.9) 5 (4.5) 0.1
Heart failure 23 (20.7) 26 (23.4) 0.6
Baseline Medications – no. (%) Beta-blocker Calcium-channel blocker Digoxin Propafenone Flecainide Sotalol Amiodarone Dofetilide Dronedarone 87 (78.4) 31 (27.9) 19 (17.1) 6 (5.4) 3 (2.7) 9 (8.1) 22 (19.8) 0 (0) 21 (18.9) 90 (81.1) 35 (31.5) 14 (12.6) 6 (5.4) 5 (4.5) 10 (9) 10 (9) 0 (0) 20 (18) 0.6 0.6 0.3 1 0.5 0.8 0.02 1 0.9
CHA2DS2-VASc - no. (%) 0.3
0 14 (12.6) 13 (11.7)
1 29 (26.1) 22 (19.8)
2 23 (20.7) 19 (17.1)
> 2 45 (40.5) 57 (51.4)